ANAVEX LIFE SCIENCES CORP. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.97 million shares for the 12-month period ending 2025-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-12-31 was 14.86M shares, a 4.12% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-12-31 was 14.27M shares, a 5.50% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-12-31 was 13.53M shares, a 18.60% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 11.51M shares.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 14.97M shares, a 0.51% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 15.05M shares, a 5.44% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.27M shares, a 7.07% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 13.33M shares, a 15.50% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2025-09-30 | 14.97M shares 10-K/A · filed 2026-08-28 | |||
| 2024-12-31 | 14.86M shares 10-Q · filed 2025-02-12 | |||
| 2024-09-30 | 15.05M shares 10-K/A · filed 2026-08-28 | |||
| 2024-06-30 | 15.19M shares 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 15.76M shares 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 14.27M shares 10-Q · filed 2025-02-12 | |||
| 2023-09-30 | 14.27M shares 10-K/A · filed 2026-08-28 | |||
| 2023-06-30 | 14.86M shares 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | 15.00M shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 13.53M shares 10-Q · filed 2024-02-07 | |||
| 2022-09-30 | 13.33M shares 10-K · filed 2023-11-27 | |||
| 2022-06-30 | 13.19M shares 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | 11.51M shares 10-Q · filed 2022-05-10 | 11.51M shares 10-Q · filed 2023-05-09 | ||
| 2021-12-31 | 11.40M shares 10-Q · filed 2023-02-07 | |||
| 2021-09-30 | 11.54M shares 10-K · filed 2023-11-27 | |||
| 2021-06-30 | 11.06M shares 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 11.51M shares 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | 11.80M shares 10-Q · filed 2021-02-16 | |||
| 2020-09-30 | 10.58M shares 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |